Aloxiprin

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Aloxiprin
Accession Number
DB13509
Type
Small Molecule
Groups
Experimental
Description
Not Available
Structure
Thumb
Synonyms
Not Available
Categories
UNII
6QT214X4XU
CAS number
9014-67-9
Weight
Average: 282.119
Monoisotopic: 281.9900796
Chemical Formula
C9H8Al2O7
InChI Key
MXCPYJZDGPQDRA-UHFFFAOYSA-N
InChI
InChI=1S/C9H8O4.2Al.3O/c1-6(10)13-8-5-3-2-4-7(8)9(11)12;;;;;/h2-5H,1H3,(H,11,12);;;;;/q;2*+3;3*-2
IUPAC Name
dialuminium(3+) ion 2-(acetyloxy)benzoic acid trioxidandiide
SMILES
[O--].[O--].[O--].[Al+3].[Al+3].CC(=O)OC1=CC=CC=C1C(O)=O

Pharmacology

Indication
Not Available
Structured Indications
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteractionDrug group
16-BromoepiandrosteroneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with 16-Bromoepiandrosterone.Investigational
19-norandrostenedioneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with 19-norandrostenedione.Experimental, Illicit
5-androstenedioneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with 5-androstenedione.Experimental, Illicit
AbciximabThe risk or severity of adverse effects can be increased when Abciximab is combined with Aloxiprin.Approved
AcarboseAloxiprin may increase the hypoglycemic activities of Acarbose.Approved, Investigational
AcenocoumarolAloxiprin may increase the anticoagulant activities of Acenocoumarol.Approved, Investigational
AcetazolamideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Acetazolamide.Approved, Vet Approved
Acetylsalicylic acidThe risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Aloxiprin.Approved, Vet Approved
AlbiglutideAloxiprin may increase the hypoglycemic activities of Albiglutide.Approved
AlclometasoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Alclometasone.Approved
AldosteroneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Aldosterone.Experimental, Investigational
AlogliptinAloxiprin may increase the hypoglycemic activities of Alogliptin.Approved
AlprostadilThe risk or severity of adverse effects can be increased when Alprostadil is combined with Aloxiprin.Approved, Investigational
AlteplaseThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Alteplase.Approved
AmcinonideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Amcinonide.Approved
Aminosalicylic AcidThe risk or severity of adverse effects can be increased when Aminosalicylic Acid is combined with Aloxiprin.Approved
Ammonium chlorideThe serum concentration of Aloxiprin can be increased when it is combined with Ammonium chloride.Approved, Investigational, Vet Approved
AnagrelideThe risk or severity of adverse effects can be increased when Anagrelide is combined with Aloxiprin.Approved
AncrodAloxiprin may increase the anticoagulant activities of Ancrod.Approved, Investigational
AndrographolideThe risk or severity of adverse effects can be increased when Andrographolide is combined with Aloxiprin.Investigational
AndrostenedioneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Androstenedione.Experimental, Illicit
AnecortaveThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Anecortave.Investigational
anecortave acetateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with anecortave acetate.Investigational
AnistreplaseThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Anistreplase.Approved
Antithrombin III humanAloxiprin may increase the anticoagulant activities of Antithrombin III human.Approved
ApixabanAloxiprin may increase the anticoagulant activities of Apixaban.Approved
AprotininThe therapeutic efficacy of Aloxiprin can be decreased when used in combination with Aprotinin.Approved, Investigational, Withdrawn
ArdeparinAloxiprin may increase the anticoagulant activities of Ardeparin.Approved, Investigational, Withdrawn
ArgatrobanThe risk or severity of adverse effects can be increased when Argatroban is combined with Aloxiprin.Approved, Investigational
AstaxanthinThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Astaxanthin.Investigational
AtamestaneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Atamestane.Investigational
AzelastineThe risk or severity of adverse effects can be increased when Azelastine is combined with Aloxiprin.Approved
AzosemideThe therapeutic efficacy of Azosemide can be decreased when used in combination with Aloxiprin.Investigational
BalsalazideThe risk or severity of adverse effects can be increased when Balsalazide is combined with Aloxiprin.Approved, Investigational
BatroxobinThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Batroxobin.Experimental
BecaplerminAloxiprin may increase the anticoagulant activities of Becaplermin.Approved, Investigational
Beclomethasone dipropionateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Beclomethasone dipropionate.Approved, Investigational
BemiparinThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Bemiparin.Approved, Investigational
BenazeprilThe therapeutic efficacy of Benazepril can be decreased when used in combination with Aloxiprin.Approved, Investigational
BeraprostThe risk or severity of adverse effects can be increased when Beraprost is combined with Aloxiprin.Investigational
BetamethasoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Betamethasone.Approved, Vet Approved
BivalirudinAloxiprin may increase the anticoagulant activities of Bivalirudin.Approved, Investigational
BrinaseThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Brinase.Experimental
BrinzolamideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Brinzolamide.Approved
BromocriptineAloxiprin may increase the hypoglycemic activities of Bromocriptine.Approved, Investigational
BudesonideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Budesonide.Approved
BuflomedilThe risk or severity of adverse effects can be increased when Buflomedil is combined with Aloxiprin.Experimental
BumetanideThe therapeutic efficacy of Bumetanide can be decreased when used in combination with Aloxiprin.Approved
ButylphthalideThe risk or severity of adverse effects can be increased when Butylphthalide is combined with Aloxiprin.Investigational
CanagliflozinAloxiprin may increase the hypoglycemic activities of Canagliflozin.Approved
CandoxatrilThe therapeutic efficacy of Candoxatril can be decreased when used in combination with Aloxiprin.Experimental
CangrelorThe risk or severity of adverse effects can be increased when Cangrelor is combined with Aloxiprin.Approved
CaplacizumabThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Caplacizumab.Investigational
CaptoprilThe therapeutic efficacy of Captopril can be decreased when used in combination with Aloxiprin.Approved
Carbaspirin calciumThe risk or severity of adverse effects can be increased when Carbaspirin calcium is combined with Aloxiprin.Experimental, Investigational
CertoparinAloxiprin may increase the anticoagulant activities of Certoparin.Approved, Investigational
ChlorpropamideAloxiprin may increase the hypoglycemic activities of Chlorpropamide.Approved, Investigational
CiclesonideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Ciclesonide.Approved, Investigational
CilazaprilThe therapeutic efficacy of Cilazapril can be decreased when used in combination with Aloxiprin.Approved
CilostazolThe risk or severity of adverse effects can be increased when Cilostazol is combined with Aloxiprin.Approved, Investigational
Citric AcidAloxiprin may increase the anticoagulant activities of Citric Acid.Approved, Nutraceutical, Vet Approved
ClobetasolThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Clobetasol.Approved, Investigational
Clobetasol propionateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Clobetasol propionate.Approved
ClobetasoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Clobetasone.Approved
ClocortoloneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Clocortolone.Approved
ClopidogrelThe risk or severity of adverse effects can be increased when Clopidogrel is combined with Aloxiprin.Approved
CloricromenThe risk or severity of adverse effects can be increased when Cloricromen is combined with Aloxiprin.Experimental
ClorindioneAloxiprin may increase the anticoagulant activities of Clorindione.Experimental
Cortexolone 17α-propionateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Cortexolone 17α-propionate.Investigational
CorticosteroneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Corticosterone.Experimental
Cortisone acetateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Cortisone acetate.Approved, Investigational
Dabigatran etexilateAloxiprin may increase the anticoagulant activities of Dabigatran etexilate.Approved
DalteparinAloxiprin may increase the anticoagulant activities of Dalteparin.Approved
DanaparoidAloxiprin may increase the anticoagulant activities of Danaparoid.Approved, Withdrawn
DapagliflozinAloxiprin may increase the hypoglycemic activities of Dapagliflozin.Approved
DarexabanAloxiprin may increase the anticoagulant activities of Darexaban.Investigational
DefibrotideThe risk or severity of adverse effects can be increased when Defibrotide is combined with Aloxiprin.Approved, Investigational
DeflazacortThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Deflazacort.Approved, Investigational
DelaprilThe therapeutic efficacy of Delapril can be decreased when used in combination with Aloxiprin.Experimental
DersalazineThe risk or severity of adverse effects can be increased when Dersalazine is combined with Aloxiprin.Investigational
DesirudinAloxiprin may increase the anticoagulant activities of Desirudin.Approved
DesmoteplaseThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Desmoteplase.Investigational
DesonideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Desonide.Approved, Investigational
DesoximetasoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Desoximetasone.Approved
Desoxycorticosterone acetateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Desoxycorticosterone acetate.Approved
Desoxycorticosterone PivalateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Desoxycorticosterone Pivalate.Experimental, Vet Approved
DexamethasoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Dexamethasone.Approved, Investigational, Vet Approved
Dexamethasone isonicotinateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Dexamethasone isonicotinate.Vet Approved
DexketoprofenThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Dexketoprofen.Approved, Investigational
DextranAloxiprin may increase the anticoagulant activities of Dextran.Approved, Investigational, Vet Approved
Dextran 40Aloxiprin may increase the anticoagulant activities of Dextran 40.Approved
Dextran 70Aloxiprin may increase the anticoagulant activities of Dextran 70.Approved
Dextran 75Aloxiprin may increase the anticoagulant activities of Dextran 75.Approved
DiclofenamideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Diclofenamide.Approved, Investigational
DicoumarolAloxiprin may increase the anticoagulant activities of Dicoumarol.Approved
DiflorasoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Diflorasone.Approved
DiflunisalThe risk or severity of adverse effects can be increased when Diflunisal is combined with Aloxiprin.Approved, Investigational
DifluocortoloneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Difluocortolone.Approved, Investigational, Withdrawn
DifluprednateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Difluprednate.Approved
DiltiazemDiltiazem may increase the anticoagulant activities of Aloxiprin.Approved, Investigational
DiphenadioneAloxiprin may increase the anticoagulant activities of Diphenadione.Experimental
DipyridamoleThe risk or severity of adverse effects can be increased when Dipyridamole is combined with Aloxiprin.Approved
DisopyramideAloxiprin may increase the hypoglycemic activities of Disopyramide.Approved
DitazoleThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Ditazole.Approved, Withdrawn
DorzolamideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Dorzolamide.Approved
Drotrecogin alfaThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Drotrecogin alfa.Approved, Investigational, Withdrawn
DulaglutideAloxiprin may increase the hypoglycemic activities of Dulaglutide.Approved, Investigational
Edetic AcidAloxiprin may increase the anticoagulant activities of Edetic Acid.Approved, Vet Approved
EdoxabanAloxiprin may increase the anticoagulant activities of Edoxaban.Approved
EmpagliflozinAloxiprin may increase the hypoglycemic activities of Empagliflozin.Approved
EnalaprilThe therapeutic efficacy of Enalapril can be decreased when used in combination with Aloxiprin.Approved, Vet Approved
EnalaprilatThe therapeutic efficacy of Enalaprilat can be decreased when used in combination with Aloxiprin.Approved
EnoxaparinAloxiprin may increase the anticoagulant activities of Enoxaparin.Approved
EpinastineThe risk or severity of adverse effects can be increased when Epinastine is combined with Aloxiprin.Approved, Investigational
EplivanserinThe risk or severity of adverse effects can be increased when Eplivanserin is combined with Aloxiprin.Investigational
eplivanserineThe risk or severity of adverse effects can be increased when eplivanserine is combined with Aloxiprin.Investigational
EpoprostenolThe risk or severity of adverse effects can be increased when Epoprostenol is combined with Aloxiprin.Approved
EptifibatideThe risk or severity of adverse effects can be increased when Eptifibatide is combined with Aloxiprin.Approved, Investigational
EquileninThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Equilenin.Experimental
EquilinThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Equilin.Approved
EstroneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Estrone.Approved
Estrone sulfateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Estrone sulfate.Approved
Etacrynic acidThe therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Aloxiprin.Approved, Investigational
EthoxzolamideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Ethoxzolamide.Withdrawn
Ethyl biscoumacetateAloxiprin may increase the anticoagulant activities of Ethyl biscoumacetate.Withdrawn
ExenatideAloxiprin may increase the hypoglycemic activities of Exenatide.Approved, Investigational
Ferulic acidAloxiprin may increase the anticoagulant activities of Ferulic acid.Experimental
FibrinolysinThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Fibrinolysin.Investigational
FluasteroneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Fluasterone.Investigational
FludrocortisoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Fludrocortisone.Approved, Investigational
FluindioneAloxiprin may increase the anticoagulant activities of Fluindione.Approved, Investigational
FlumethasoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Flumethasone.Approved, Vet Approved
FlunisolideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Flunisolide.Approved, Investigational
Fluocinolone AcetonideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Fluocinolone Acetonide.Approved, Investigational, Vet Approved
FluocinonideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Fluocinonide.Approved, Investigational
FluocortoloneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Fluocortolone.Approved, Withdrawn
FluorometholoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Fluorometholone.Approved, Investigational
FluprednideneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Fluprednidene.Approved, Withdrawn
FluprednisoloneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Fluprednisolone.Approved
FlurandrenolideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Flurandrenolide.Approved
Fluticasone furoateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Fluticasone furoate.Approved
Fluticasone propionateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Fluticasone propionate.Approved
FondaparinuxAloxiprin may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
Fondaparinux sodiumAloxiprin may increase the anticoagulant activities of Fondaparinux sodium.Approved, Investigational
FormestaneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Formestane.Approved, Investigational, Withdrawn
FosinoprilThe therapeutic efficacy of Fosinopril can be decreased when used in combination with Aloxiprin.Approved
FurosemideThe therapeutic efficacy of Furosemide can be decreased when used in combination with Aloxiprin.Approved, Vet Approved
GabexateAloxiprin may increase the anticoagulant activities of Gabexate.Investigational
Ginkgo bilobaGinkgo biloba may increase the anticoagulant activities of Aloxiprin.Approved, Investigational, Nutraceutical
GliclazideAloxiprin may increase the hypoglycemic activities of Gliclazide.Approved
GlimepirideAloxiprin may increase the hypoglycemic activities of Glimepiride.Approved
GlipizideAloxiprin may increase the hypoglycemic activities of Glipizide.Approved, Investigational
GlyburideAloxiprin may increase the hypoglycemic activities of Glyburide.Approved
GuacetisalThe risk or severity of adverse effects can be increased when Guacetisal is combined with Aloxiprin.Experimental
HalcinonideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Halcinonide.Approved, Investigational, Withdrawn
HE3286The risk or severity of adverse effects can be increased when Aloxiprin is combined with HE3286.Investigational
Hemoglobin crosfumarilThe risk or severity of adverse effects can be increased when Hemoglobin crosfumaril is combined with Aloxiprin.Experimental
HeparinAloxiprin may increase the anticoagulant activities of Heparin.Approved, Investigational
HigenamineThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Higenamine.Investigational
HyaluronidaseThe therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Aloxiprin.Approved, Investigational
HydrocortisoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Hydrocortisone.Approved, Vet Approved
HydroxytyrosolThe risk or severity of adverse effects can be increased when Hydroxytyrosol is combined with Aloxiprin.Investigational
IbudilastThe risk or severity of adverse effects can be increased when Ibudilast is combined with Aloxiprin.Approved, Investigational
Icosapent ethylThe risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Aloxiprin.Approved, Investigational, Nutraceutical
IdraparinuxAloxiprin may increase the anticoagulant activities of Idraparinux.Investigational
IfenprodilThe risk or severity of adverse effects can be increased when Ifenprodil is combined with Aloxiprin.Approved, Investigational, Withdrawn
IfetrobanThe risk or severity of adverse effects can be increased when Ifetroban is combined with Aloxiprin.Investigational
IloprostThe risk or severity of adverse effects can be increased when Iloprost is combined with Aloxiprin.Approved, Investigational
ImidaprilThe therapeutic efficacy of Imidapril can be decreased when used in combination with Aloxiprin.Investigational
IndobufenThe risk or severity of adverse effects can be increased when Indobufen is combined with Aloxiprin.Investigational
Insulin AspartAloxiprin may increase the hypoglycemic activities of Insulin Aspart.Approved
Insulin DetemirAloxiprin may increase the hypoglycemic activities of Insulin Detemir.Approved
Insulin GlargineAloxiprin may increase the hypoglycemic activities of Insulin Glargine.Approved
Insulin GlulisineAloxiprin may increase the hypoglycemic activities of Insulin Glulisine.Approved
Insulin HumanAloxiprin may increase the hypoglycemic activities of Insulin Human.Approved, Investigational
Insulin LisproAloxiprin may increase the hypoglycemic activities of Insulin Lispro.Approved
IstaroximeThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Istaroxime.Investigational
KetanserinThe risk or severity of adverse effects can be increased when Ketanserin is combined with Aloxiprin.Investigational
LepirudinAloxiprin may increase the anticoagulant activities of Lepirudin.Approved
LetaxabanAloxiprin may increase the anticoagulant activities of Letaxaban.Investigational
LimaprostThe risk or severity of adverse effects can be increased when Limaprost is combined with Aloxiprin.Approved, Investigational
LinsidomineThe risk or severity of adverse effects can be increased when Linsidomine is combined with Aloxiprin.Experimental
LiraglutideAloxiprin may increase the hypoglycemic activities of Liraglutide.Approved
LisinoprilThe therapeutic efficacy of Lisinopril can be decreased when used in combination with Aloxiprin.Approved, Investigational
LoteprednolThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Loteprednol.Approved
ME-609The risk or severity of adverse effects can be increased when Aloxiprin is combined with ME-609.Investigational
MecaserminAloxiprin may increase the hypoglycemic activities of Mecasermin.Approved, Investigational
MedrysoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Medrysone.Approved
MelagatranAloxiprin may increase the anticoagulant activities of Melagatran.Experimental
MelengestrolThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Melengestrol.Vet Approved
MesalazineThe risk or severity of adverse effects can be increased when Mesalazine is combined with Aloxiprin.Approved
MetforminAloxiprin may increase the hypoglycemic activities of Metformin.Approved
MethazolamideThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Methazolamide.Approved
MethotrexateThe serum concentration of Methotrexate can be increased when it is combined with Aloxiprin.Approved
Methyl salicylateThe risk or severity of adverse effects can be increased when Methyl salicylate is combined with Aloxiprin.Approved, Vet Approved
MethylprednisoloneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Methylprednisolone.Approved, Vet Approved
MifepristoneAloxiprin may increase the hypoglycemic activities of Mifepristone.Approved, Investigational
MiglitolAloxiprin may increase the hypoglycemic activities of Miglitol.Approved
MilrinoneThe risk or severity of adverse effects can be increased when Milrinone is combined with Aloxiprin.Approved
MoexiprilThe therapeutic efficacy of Moexipril can be decreased when used in combination with Aloxiprin.Approved
MometasoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Mometasone.Approved, Vet Approved
NadroparinAloxiprin may increase the anticoagulant activities of Nadroparin.Approved, Investigational
NafamostatAloxiprin may increase the anticoagulant activities of Nafamostat.Approved, Investigational
NaftopidilThe risk or severity of adverse effects can be increased when Naftopidil is combined with Aloxiprin.Investigational
NateglinideAloxiprin may increase the hypoglycemic activities of Nateglinide.Approved, Investigational
NCX 1022The risk or severity of adverse effects can be increased when Aloxiprin is combined with NCX 1022.Investigational
NimesulideThe risk or severity of adverse effects can be increased when Nimesulide is combined with Aloxiprin.Approved, Investigational, Withdrawn
NitroaspirinThe risk or severity of adverse effects can be increased when Nitroaspirin is combined with Aloxiprin.Investigational
Oleoyl-estroneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Oleoyl-estrone.Investigational
OlsalazineThe risk or severity of adverse effects can be increased when Olsalazine is combined with Aloxiprin.Approved
OmapatrilatThe therapeutic efficacy of Omapatrilat can be decreased when used in combination with Aloxiprin.Investigational
OtamixabanAloxiprin may increase the anticoagulant activities of Otamixaban.Investigational
OzagrelThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Ozagrel.Investigational
ParamethasoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Paramethasone.Approved
ParnaparinThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Parnaparin.Approved, Investigational
Pentaerythritol TetranitrateAloxiprin may increase the anticoagulant activities of Pentaerythritol Tetranitrate.Approved
PentamidineAloxiprin may increase the hypoglycemic activities of Pentamidine.Approved, Investigational
Pentosan PolysulfateAloxiprin may increase the anticoagulant activities of Pentosan Polysulfate.Approved
PentoxifyllineThe risk or severity of adverse effects can be increased when Pentoxifylline is combined with Aloxiprin.Approved, Investigational
PerindoprilThe therapeutic efficacy of Perindopril can be decreased when used in combination with Aloxiprin.Approved
PhenindioneAloxiprin may increase the anticoagulant activities of Phenindione.Approved, Investigational
PhenprocoumonAloxiprin may increase the anticoagulant activities of Phenprocoumon.Approved, Investigational
Phenyl aminosalicylateThe risk or severity of adverse effects can be increased when Phenyl aminosalicylate is combined with Aloxiprin.Approved
PicotamideThe risk or severity of adverse effects can be increased when Picotamide is combined with Aloxiprin.Experimental
PioglitazoneAloxiprin may increase the hypoglycemic activities of Pioglitazone.Approved, Investigational
PiretanideThe therapeutic efficacy of Piretanide can be decreased when used in combination with Aloxiprin.Approved
PralatrexateThe serum concentration of Pralatrexate can be increased when it is combined with Aloxiprin.Approved, Investigational
PramlintideAloxiprin may increase the hypoglycemic activities of Pramlintide.Approved, Investigational
PrasteroneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Prasterone.Approved, Investigational, Nutraceutical
Prasterone sulfateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Prasterone sulfate.Investigational
PrasugrelThe risk or severity of adverse effects can be increased when Prasugrel is combined with Aloxiprin.Approved
PrednicarbateThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Prednicarbate.Approved, Investigational
PrednisoloneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Prednisolone.Approved, Vet Approved
PrednisoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Prednisone.Approved, Vet Approved
PregnenoloneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Pregnenolone.Approved, Experimental, Investigational
ProbenecidThe therapeutic efficacy of Probenecid can be decreased when used in combination with Aloxiprin.Approved, Investigational
Protein CAloxiprin may increase the anticoagulant activities of Protein C.Approved
Protein S humanAloxiprin may increase the anticoagulant activities of Protein S human.Approved
ProtocatechualdehydeAloxiprin may increase the anticoagulant activities of Protocatechualdehyde.Approved
QuinaprilThe therapeutic efficacy of Quinapril can be decreased when used in combination with Aloxiprin.Approved, Investigational
QuinineAloxiprin may increase the hypoglycemic activities of Quinine.Approved
RamatrobanThe risk or severity of adverse effects can be increased when Ramatroban is combined with Aloxiprin.Investigational
RamiprilThe therapeutic efficacy of Ramipril can be decreased when used in combination with Aloxiprin.Approved
RelcovaptanThe risk or severity of adverse effects can be increased when Relcovaptan is combined with Aloxiprin.Investigational
RepaglinideAloxiprin may increase the hypoglycemic activities of Repaglinide.Approved, Investigational
RescinnamineThe therapeutic efficacy of Rescinnamine can be decreased when used in combination with Aloxiprin.Approved
ResveratrolThe risk or severity of adverse effects can be increased when Resveratrol is combined with Aloxiprin.Approved, Experimental, Investigational
ReteplaseThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Reteplase.Approved, Investigational
ReviparinAloxiprin may increase the anticoagulant activities of Reviparin.Approved, Investigational
RidogrelThe risk or severity of adverse effects can be increased when Ridogrel is combined with Aloxiprin.Approved
RimexoloneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Rimexolone.Approved
RivaroxabanAloxiprin may increase the anticoagulant activities of Rivaroxaban.Approved
RosiglitazoneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Rosiglitazone.Approved, Investigational
Salicylic acidThe risk or severity of adverse effects can be increased when Salicylic acid is combined with Aloxiprin.Approved, Investigational, Vet Approved
SarpogrelateThe risk or severity of adverse effects can be increased when Sarpogrelate is combined with Aloxiprin.Investigational
SaruplaseThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Saruplase.Experimental
SaxagliptinAloxiprin may increase the hypoglycemic activities of Saxagliptin.Approved
SelexipagThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Selexipag.Approved
SevofluraneThe risk or severity of adverse effects can be increased when Sevoflurane is combined with Aloxiprin.Approved, Vet Approved
SitagliptinAloxiprin may increase the hypoglycemic activities of Sitagliptin.Approved, Investigational
SpiraprilThe therapeutic efficacy of Spirapril can be decreased when used in combination with Aloxiprin.Approved
SRT501The risk or severity of adverse effects can be increased when SRT501 is combined with Aloxiprin.Investigational
StreptokinaseThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Streptokinase.Approved, Investigational
SulfadiazineAloxiprin may increase the hypoglycemic activities of Sulfadiazine.Approved, Investigational, Vet Approved
SulfamethoxazoleAloxiprin may increase the hypoglycemic activities of Sulfamethoxazole.Approved
SulfisoxazoleAloxiprin may increase the hypoglycemic activities of Sulfisoxazole.Approved, Vet Approved
SulodexideAloxiprin may increase the anticoagulant activities of Sulodexide.Approved, Investigational
SunitinibAloxiprin may increase the hypoglycemic activities of Sunitinib.Approved, Investigational
TemocaprilThe therapeutic efficacy of Temocapril can be decreased when used in combination with Aloxiprin.Experimental, Investigational
TenecteplaseThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Tenecteplase.Approved
TesmilifeneThe risk or severity of adverse effects can be increased when Tesmilifene is combined with Aloxiprin.Investigational
TicagrelorThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Ticagrelor.Approved
TiclopidineThe risk or severity of adverse effects can be increased when Ticlopidine is combined with Aloxiprin.Approved
TinzaparinThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Tinzaparin.Approved
TioclomarolAloxiprin may increase the anticoagulant activities of Tioclomarol.Experimental
TirofibanThe risk or severity of adverse effects can be increased when Tirofiban is combined with Aloxiprin.Approved
TixocortolThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Tixocortol.Approved, Withdrawn
TolazamideAloxiprin may increase the hypoglycemic activities of Tolazamide.Approved, Investigational
TolbutamideAloxiprin may increase the hypoglycemic activities of Tolbutamide.Approved, Investigational
TorasemideThe therapeutic efficacy of Torasemide can be decreased when used in combination with Aloxiprin.Approved
TrandolaprilThe therapeutic efficacy of Trandolapril can be decreased when used in combination with Aloxiprin.Approved
TranilastThe risk or severity of adverse effects can be increased when Tranilast is combined with Aloxiprin.Approved, Investigational
TrapidilThe risk or severity of adverse effects can be increased when Trapidil is combined with Aloxiprin.Approved
TreprostinilThe risk or severity of adverse effects can be increased when Treprostinil is combined with Aloxiprin.Approved, Investigational
TriamcinoloneThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Triamcinolone.Approved, Vet Approved
TriflusalThe risk or severity of adverse effects can be increased when Triflusal is combined with Aloxiprin.Approved, Investigational
Trolamine salicylateThe risk or severity of adverse effects can be increased when Trolamine salicylate is combined with Aloxiprin.Approved
TroxerutinAloxiprin may increase the anticoagulant activities of Troxerutin.Investigational
UlobetasolThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Ulobetasol.Approved
UrokinaseThe risk or severity of adverse effects can be increased when Aloxiprin is combined with Urokinase.Approved, Investigational, Withdrawn
Valproic AcidThe serum concentration of Valproic Acid can be increased when it is combined with Aloxiprin.Approved, Investigational
VerapamilVerapamil may increase the anticoagulant activities of Aloxiprin.Approved
VorapaxarThe risk or severity of adverse effects can be increased when Vorapaxar is combined with Aloxiprin.Approved
WarfarinAloxiprin may increase the anticoagulant activities of Warfarin.Approved
XimelagatranAloxiprin may increase the anticoagulant activities of Ximelagatran.Approved, Investigational, Withdrawn
ZofenoprilThe therapeutic efficacy of Zofenopril can be decreased when used in combination with Aloxiprin.Experimental
Food Interactions
Not Available

References

General References
Not Available
External Links
ChemSpider
32698107
Wikipedia
Aloxiprin
ATC Codes
N02BA02 — AloxiprinB01AC15 — Aloxiprin

Clinical Trials

Clinical Trials
Not Available

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility36.2 mg/mLALOGPS
logP1.19ALOGPS
logP1.24ChemAxon
logS-0.76ALOGPS
pKa (Strongest Acidic)3.41ChemAxon
pKa (Strongest Basic)-7.1ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area63.6 Å2ChemAxon
Rotatable Bond Count3ChemAxon
Refractivity44.45 m3·mol-1ChemAxon
Polarizability16.96 Å3ChemAxon
Number of Rings1ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Taxonomy

Description
This compound belongs to the class of organic compounds known as acylsalicylic acids. These are o-acylated derivatives of salicylic acid.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Benzoic acids and derivatives
Direct Parent
Acylsalicylic acids
Alternative Parents
Phenol esters / Benzoic acids / Phenoxy compounds / Benzoyl derivatives / Dicarboxylic acids and derivatives / Carboxylic acid esters / Carboxylic acids / Organic oxides / Organic aluminium salts / Hydrocarbon derivatives
show 1 more
Substituents
Acylsalicylic acid / Phenol ester / Benzoic acid / Phenoxy compound / Benzoyl / Dicarboxylic acid or derivatives / Carboxylic acid ester / Carboxylic acid derivative / Carboxylic acid / Organic oxygen compound
show 7 more
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
Not Available

Drug created on June 23, 2017 14:43 / Updated on March 02, 2018 04:26